Finance ❯ Stock Market ❯ Market Trends ❯ Investor Behavior

Stock Performance

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

Topline data could support an expedited FDA filing as a second confirmatory Phase 3 trial continues.